Ignite Creation Date:
2025-12-24 @ 7:55 PM
Ignite Modification Date:
2026-01-13 @ 1:15 PM
Study NCT ID:
NCT01850004
Status:
COMPLETED
Last Update Posted:
2022-11-03
First Post:
2013-05-08
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Open-Label Study Evaluating Dasatinib Therapy Discontinuation in Patients With Chronic Phase Chronic Myeloid Leukemia With Stable Complete Molecular Response
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-01-22
Start Date Type:
ACTUAL
Primary Completion Date:
2017-09-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-10-08
Completion Date Type:
ACTUAL
First Submit Date:
2013-05-08
First Submit QC Date:
None
Study First Post Date:
2013-05-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-09-20
Results First Submit QC Date:
None
Results First Post Date:
2018-11-02
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-10-05
Last Update Post Date:
2022-11-03
Last Update Post Date Type:
ACTUAL